EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice

Kay Weipert iD, Holger Nef iD, Sandra Voss, Jedrzej Hoffmann, Sven Reischauer, Andreas Rolf iD, Kerstin Troidl, Astrid Wietelmann iD, Christian W Hamm iD, Samuel T Sossalla iD, Christian Troidl iD

Cardiovascular Therapeutics · 2025

DOI: 10.1155/cdr/8856808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Kay Weipert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Division of Cardiology, University Clinic Giessen, Giessen, Germany. Hauptthemen laut MEDLINE: Myocardial Infarction, Receptors, CCR2, Macrophages, Ventricular Remodeling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of the present study was to investigate the inhibition of classically activated macrophages in myocardial infarction (MI) under the influence of the chemokine (C‐C motif) receptor 2 (CCR2) antagonist propagermanium (PPG). Methods and Results: Mice (C57BL/6; n = 121) were subjected to occlusion of the left anterior descending artery and were randomized to the following groups: (a) MI with daily oral administration of 0.9% sodium chloride (“MI”), (b) MI with oral administration of 8 mg/kg PPG (“MI + PPG”), and (c) sham‐operated mice served as control. Mice were euthanized 2, 5, 10, or 21 days after MI for isolation of total RNA, protein, and immunofluorescence measurements. Flow cytometry was performed to investigate peripheral blood leucocytes. Scar size and cardiac function were determined by MRI on Day 7 after surgery and by trichrome staining on Day 21. PPG administration led to a significantly improved ejection fraction (MI + PPG: 38.5 % ± 3.4 % vs. MI: 23.8 % ± 3.0 % ; p < 0.05) after MI. MRI also revealed improved wall thickness (34.7 % ± 3.2 % vs. 21.8 % ± 2.9 % ; p < 0.05) associated with a diminished akinetic area (13.8 % ± 4.0 % vs. 37.3 % ± 5.6 % ; p < 0.01). Trichrome staining confirmed less collagen scar formation in the PPG‐treated group (12.7 % ± 1.4 % vs. 21.9 % ± 3.9 % ; p < 0.05). Flow cytometry showed fewer peripheral blood monocytes in MI + PPG than in MI 2 days after treatment (4.0 % ± 0.7 % vs. 12.7 % ± 1.2 % of total leucocytes; p < 0.05). Immunostaining and western blotting using activation type‐specific markers CCR2 and MRC1 demonstrated that the number of alternatively activated macrophages within the infarct zone increased, whereas the overall number was reduced after PPG treatment. PPG led to increased expression of VEGF‐ α and VEGF‐ β in THP‐1 cells in vitro and increased capillary density in vivo 2 days after MI (MI‐PPG: 1071 ± 81/mm 2 vs. MI: 648 ± 79/mm 2 ( p < 0.05)).

Conclusion

Our results suggest that altering the activation type and distribution of invading macrophages in favor of alternative activation improves cardiac remodeling and function following MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionReceptors, CCR2MacrophagesVentricular RemodelingMyocardiumGermaniumAnimalsMice, Inbred C57BLDisease Models, AnimalMaleTime FactorsVentricular Function, LeftFibrosisMiceOrganometallic CompoundsPropionates

Stichwörter der Autor:innen

CCR2macrophagesmonocytesmyocardial infarctionpropagermanium

Substanzen

Receptors, CCR2Ccr2 protein, mousepropagermaniumGermaniumOrganometallic CompoundsPropionates

Autor:innen und Institutionen

  • Department of Internal Medicine I, Division of Cardiology, University Clinic Giessen, Giessen, Germany.
  • Department of Experimental Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
  • Max-Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

ORCID-Profile: Kay Weipert, Holger Nef, Andreas Rolf, Astrid Wietelmann, Christian W Hamm, Samuel T Sossalla, Christian Troidl

Zitieren

APA

Weipert, K., Nef, H., Voss, S., Hoffmann, J., Reischauer, S., Rolf, A., Troidl, K., Wietelmann, A., Hamm, C. W., Sossalla, S. T., & Troidl, C. (2025). Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/8856808

Vancouver

Weipert K, Nef H, Voss S, Hoffmann J, Reischauer S, Rolf A, et al. Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/8856808

BibTeX
@article{Weipert2025,
  author = {Weipert, Kay and Nef, Holger and Voss, Sandra and Hoffmann, Jedrzej and Reischauer, Sven and Rolf, Andreas and Troidl, Kerstin and Wietelmann, Astrid and Hamm, Christian W and Sossalla, Samuel T and Troidl, Christian},
  title = {Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice},
  journal = {Cardiovascular Therapeutics},
  year = {2025},
  doi = {10.1155/cdr/8856808}
}
Kostenlos starten →